FMC (FMC) Jefferies Global Industrials Conference 2026 summary
Event summary combining transcript, slides, and related documents.
Jefferies Global Industrials Conference 2026 summary
10 Sep, 2026Market and industry outlook
Demand and supply in crop protection chemicals remain stable, with cautious inventory management and purchasing close to utilization time continuing into 2026 and early 2027.
No significant price increases are observed, except for some non-selective herbicides, with overall pricing trends stable.
The industry is experiencing cautious behavior, with no major shifts in market dynamics expected in the near term.
Strategic investments and deleveraging
Tessenderlo's investment was driven by belief in the long-term strategy, willingness to hold a 20% stake, and a three-year lockup, with no operational cooperation expected.
The investment supports deleveraging, with $1 billion proceeds used to pay down debt and a focus on stabilizing earnings from 2026 onward.
Tessenderlo's support centers on the Rynaxypyr strategy, manufacturing footprint changes, and new product growth.
Product pipeline and manufacturing
New manufacturing footprint is on track to be completed by Q1 2027, with full benefits expected in the second half of 2027.
Three key molecules—Dodhylex, Isoflex, and fluindapyr—are expected to drive growth, with major regulatory milestones and registrations anticipated in 2027 and 2028.
Core business is expected to return to growth immediately upon product line reset and repricing in late 2027.
Latest events from FMC
- Record 2019 growth despite headwinds, with further expansion guided for 2020.FMC
Q4 2019 - 2020 growth held firm despite FX headwinds, with higher 2021 targets and persistent supply risks.FMC
Q4 2020 - Strong growth and record free cash flow offset inflation pressure; 2022 guidance points to continued expansion.FMC
Q4 2021 - Record FY22 sales and EBITDA growth came with lower margins amid inflation and FX headwinds.FMC
Q4 2022 - Commercial actions drove a steep Q3 loss; EBITDA recovery is projected for 2027–28.FMC
Q3 2026 - Destocking drove 2023 declines; new products and restructuring support 2024 recovery.FMC
Q4 2023 - Q2 2026 revenue dropped 17% and net loss widened, but asset sales aided debt reduction.FMC
Q2 2026 - Debt reduction progresses as new molecules and direct sales boost growth and confidence.FMC
Wolfe Research 3rd Annual Materials of the Future Conference 2026 - Q3 revenue up 9% and net income rebounded, with strong Americas growth and GSS sale pending.FMC
Q3 2024